Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $8.0 billion point-of-care testing market. Chembio markets each of its DPP HIV 1/2 Assay, HIV 1/2 STAT-PAK Assay, and SURE CHECK HIV 1/2 Assay, with these Chembio brand names, in the U.S. and internationally both directly and through third-party distributors. The Company's…More SURE CHECK HIV 1/2 Assay previously has been exclusively sold in the U.S. as Clearview Complete HIV 1/2 Assay.
Chembio Diagnostics, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.
Shipping Information
Please fill out the form below and click "Place Order" to complete your order.